Nutritional factors in the prevention and management of coronary artery disease and heart failure

被引:28
|
作者
Das, Undurti N. [1 ,2 ,3 ]
机构
[1] UND Life Sci, Federal Way, WA USA
[2] Gayatri Vidya Parishad Hosp, Dept Med, Visakhapatnam, Andhra Pradesh, India
[3] Gayatri Vidya Parishad Hosp, BioSci Res Ctr, Visakhapatnam, Andhra Pradesh, India
关键词
Nutrients; Polyunsaturated fatty acids; Vitamins; Pyridoxine; Lipoxins; Resolvins; Protectins; Heart failure; Atherosclerosis; Coronary artery disease; Nitric oxide; Asymmetrical dimethylarginine; Magnesium; Eicosanoids; Arrhythmias; Cytokines; L-arginine; POLYUNSATURATED-FATTY-ACIDS; ENDOTHELIUM-DEPENDENT VASODILATION; LONG-CHAIN OMEGA-3-FATTY-ACIDS; METABOLIC SYNDROME-X; C-REACTIVE PROTEIN; ASYMMETRIC DIMETHYLARGININE; MAGNESIUM-DEFICIENCY; PLASMA HOMOCYSTEINE; DIABETES-MELLITUS; ARACHIDONIC-ACID;
D O I
10.1016/j.nut.2014.08.011
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Nutritional factors such as magnesium, folic acid, vitamins B-12 and B-6, L-arginine, and polyunsaturated fatty acids (PUFAs) appear to be significantly beneficial for patients with coronary artery disease (CAD), and in the prevention and arresting the progression of HF and cardiac arrhythmias. Additionally, ingestion of adequate amounts of protein and maintaining normal concentrations of plasma albumin seem to be essential for these patients. These nutrients closely interact with the metabolism of L-arginine-nitric oxide (NO) system, essential fatty acids, and eicosanoids such that beneficial products such as NO, prostaglandin E-1, prostacyclin, prostaglandin I-3, lipoxins, resolvins, and protectins are generated and synthesis of proinflammatory cytokines is suppressed that results in platelet anti-aggregation, vasodilation, angiogenesis, and prevention of CAD, cardiac arrhythmias, and stabilization of HF. This implies that individuals at high risk for CAD, cardiac arrhythmias, and HF and those who have these diseases need to be screened for plasma levels of magnesium, folic acid, vitamins B-12 and B-6, L-arginine, NO, various PUFAs, lipoxin A(4), resolvins, protectins, asymmetrical dimethylarginine (an endogenous inhibitor of NO), albumin, and various eicosanoids and cytokines and correct their abnormalities to restore normal physiology. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [31] Ivabradine in the treatment of heart failure and coronary artery disease
    Verschuren, J. J. W.
    Jukema, J. W.
    [J]. NETHERLANDS HEART JOURNAL, 2011, 19 : 20 - 22
  • [32] Ivabradine in the management of coronary artery disease with or without left ventricular dysfunction or heart failure
    Ferrari, Roberto
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0G) : G24 - G29
  • [33] The epidemiology of heart failure secondary to coronary artery disease
    Goldman, JH
    McKenna, WJ
    [J]. CORONARY ARTERY DISEASE, 1998, 9 (10) : 625 - 628
  • [34] Cardiovascular remodelling in coronary artery disease and heart failure
    Heusch, Gerd
    Libby, Peter
    Gersh, Bernard
    Yellon, Derek
    Boehm, Michael
    Lopaschuk, Gary
    Opie, Lionel
    [J]. LANCET, 2014, 383 (9932): : 1933 - 1943
  • [35] Hypertension, congestive heart failure and coronary artery disease
    Messerli, FH
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 223A - 223A
  • [36] Genetics: Implications for Prevention and Management of Coronary Artery Disease
    Assimes, Themistocles L.
    Roberts, Robert
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (25) : 2797 - 2818
  • [37] Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care
    Turner, D. A.
    Paul, S.
    Stone, M. A.
    Juarez-Garcia, A.
    Squire, I.
    Khunti, K.
    [J]. HEART, 2008, 94 (12) : 1601 - 1606
  • [38] Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap
    Lamblin, Nicolas
    Ninni, Sandro
    Tricot, Olivier
    Meurice, Thibaud
    Lemesle, Gilles
    Bauters, Christophe
    [J]. OPEN HEART, 2020, 7 (01):
  • [39] INCIDENCE RISK FACTORS AND PREVENTION OF CORONARY HEART DISEASE
    BRASSEUR, LA
    [J]. LOUVAIN MEDICAL, 1974, 93 (01): : 5 - 15
  • [40] CORONARY HEART-DISEASE, PREVENTION, AND WORK FACTORS
    OPIT, LJ
    SALZBERG, MR
    [J]. LANCET, 1983, 2 (8344): : 289 - 289